查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1417485

HIV診斷市場報告：至2030年的趨勢、預測與競爭分析

HIV Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

HIV診斷趨勢與預測

到2030年，全球愛滋病毒診斷市場預計將達到 76 億美元，2024年至2030年年複合成長率為 10.1%。該市場的主要驅動力是捐血和輸血數量的增加、照護現場設備和消耗品的好處以及與愛滋病毒相關的政府措施的數量增加。全球愛滋病毒診斷市場的未來看起來充滿希望，診斷實驗室和醫院市場充滿機會。

HIV 診斷市場洞察

Lucintel 預測抗體檢測將在預測期內達到最高成長。

由於醫療基礎設施的成長和愛滋病毒感染率高增加了對高效醫療服務的需求，北美在預測期內可能仍然是最大的地區。

常問問題

Q1.市場規模有多大？

A1.到2030年，全球 HIV 診斷市場預計將達到 76 億美元。

Q2.市場成長預測如何？

A2.預計2024年至2030年，全球愛滋病毒診斷市場將以 10.1%的年複合成長率成長。

Q3.影響市場成長的主要促進因素有哪些？

A3.該市場的主要驅動力是捐血和輸血數量的增加、照護現場設備和消耗品的好處以及與愛滋病毒相關的政府措施的增加。

Q4.市場的主要細分市場是什麼？

A4.全球愛滋病毒診斷市場的未來充滿希望，診斷實驗室和醫院市場充滿機會。

Q5.市場上主要企業有哪些？

A5.愛滋病診斷的主要企業如下。

  • Siemens Healthineers
  • F. Hoffmann-La Roche
  • Abbott Laboratories
  • Danaher
  • Thermo-Fisher Scientific

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預計抗體測試將在預測期內達到最高成長。

Q7.未來五年預計哪個地區將成為最大的市場？

A7.在預測期內，北美將繼續成為最大的地區，因為醫療保健基礎設施的成長和愛滋病毒感染率高增加了對高效醫療保健服務的需求。

Q8.可以客製化報告嗎？

A8.是的，Lucintel 提供 10%的客製化服務，無需額外付費。

目錄

第1章 執行摘要

第2章 全球愛滋病毒診斷市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球愛滋病毒診斷市場趨勢（2018-2023）與預測（2024-2030）
  • 全球愛滋病毒診斷市場（依產品）
    • 消耗品
    • 裝置
    • 軟體和服務
  • 按測試類型分類的全球愛滋病毒診斷市場
    • 抗體測試
    • 病毒量測試
    • CD4測試
    • 其他
  • 依最終用途分類的全球愛滋病毒診斷市場
    • 診斷實驗室
    • 醫院
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球愛滋病毒診斷市場（依地區）
  • 北美HIV診斷市場
  • 歐洲愛滋病毒診斷市場
  • 亞太地區愛滋病毒診斷市場
  • 其他地區HIV診斷市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球愛滋病毒診斷市場成長機會（依產品）
    • 全球愛滋病毒診斷市場成長機會（按測試類型）
    • 全球愛滋病毒診斷市場成長機會（依最終用途）
    • 全球愛滋病毒診斷市場成長機會（依地區）
  • 全球愛滋病毒診斷市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球愛滋病毒診斷市場的能力
    • 全球愛滋病毒診斷市場的合併、收購和合資企業
    • 認證和許可

第7章 主要企業概況

  • Siemens Healthineers
  • F. Hoffmann-La Roche
  • Abbott Laboratories
  • Danaher
  • Thermo-Fisher Scientific
簡介目錄

HIV Diagnostic Trends and Forecast

The future of the global HIV diagnostic market looks promising with opportunities in the diagnostic laboratories and hospital markets. The global HIV diagnostic market is expected to reach an estimated $7.6 billion by 2030 with a CAGR of 10.1% from 2024 to 2030. The major drivers for this market are growing number of blood donations and transfusions, advantages provided by point-of-care equipment & supplies, and increasing HIV-related government initiatives.

A more than 150-page report is developed to help in your business decisions.

HIV Diagnostic by Segment

The study includes a forecast for the global HIV diagnostic by product, test type, end use, and region.

HIV Diagnostic Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Consumables
  • Instruments
  • Software & Services

HIV Diagnostic Market by Test Type [Shipment Analysis by Value from 2018 to 2030]:

  • Antibody Tests
  • Viral Load Tests
  • CD4 Tests
  • Others

HIV Diagnostic Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Diagnostic Laboratories
  • Hospitals
  • Others

HIV Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of HIV Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies HIV diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the HIV diagnostic companies profiled in this report include-

  • Siemens Healthineers
  • F. Hoffmann-La Roche
  • Abbott Laboratories
  • Danaher
  • Thermo-Fisher Scientific

HIV Diagnostic Market Insights

Lucintel forecasts that antibody test is expected to witness the highest growth over the forecast period.

North America will remain the largest region over the forecast period due to growing healthcare infrastructure and the high prevalence of HIV infection that have resulted in a greater need for efficient healthcare services.

Features of the Global HIV Diagnostic Market

Market Size Estimates: HIV Diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: HIV Diagnostic market size by product, test type, end use, and region in terms of value ($B).

Regional Analysis: HIV Diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product, test type, end use, and regions for the HIV diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the HIV diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the HIV diagnostic market size?

Answer: The global HIV diagnostic market is expected to reach an estimated $7.6 billion by 2030.

Q2. What is the growth forecast for HIV diagnostic market?

Answer: The global HIV diagnostic market is expected to grow with a CAGR of 10.1% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the HIV diagnostic market?

Answer: The major drivers for this market are growing number of blood donations and transfusions, advantages provided by point-of-care equipment & supplies, and increasing HIV-related government initiatives.

Q4. What are the major segments for HIV diagnostic market?

Answer: The future of the global HIV diagnostic market looks promising with opportunities in the diagnostic laboratories and hospital markets.

Q5. Who are the key HIV diagnostic market companies?

Answer: Some of the key HIV diagnostic companies are as follows.

  • Siemens Healthineers
  • F. Hoffmann-La Roche
  • Abbott Laboratories
  • Danaher
  • Thermo-Fisher Scientific

Q6. Which HIV diagnostic market segment will be the largest in future?

Answer: Lucintel forecasts that antibody test is expected to witness the highest growth over the forecast period.

Q7. In HIV diagnostic market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to growing healthcare infrastructure and the high prevalence of HIV infection that have resulted in a greater need for efficient healthcare services.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the HIV diagnostic market by product (consumables, instruments, and software & services), test type (antibody tests, viral load tests, CD4 tests, and others), end use (diagnostic laboratories, hospitals, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global HIV Diagnostic Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global HIV Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global HIV Diagnostic Market by Product
    • 3.3.1: Consumables
    • 3.3.2: Instruments
    • 3.3.3: Software & Services
  • 3.4: Global HIV Diagnostic Market by Test Type
    • 3.4.1: Antibody Tests
    • 3.4.2: Viral Load Tests
    • 3.4.3: CD4 Tests
    • 3.4.4: Others
  • 3.5: Global HIV Diagnostic Market by End Use
    • 3.5.1: Diagnostic Laboratories
    • 3.5.2: Hospitals
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global HIV Diagnostic Market by Region
  • 4.2: North American HIV Diagnostic Market
    • 4.2.1: North American HIV Diagnostics Market by Test Type: Antibody Tests, Viral Load Tests, CD4 Tests, and Others
    • 4.2.2: North American HIV Diagnostics Market by End Use: Diagnostic Laboratories, Hospitals, and Others
  • 4.3: European HIV Diagnostic Market
    • 4.3.1: European HIV Diagnostics Market by Test Type: Antibody Tests, Viral Load Tests, CD4 Tests, and Others
    • 4.3.2: European HIV Diagnostics Market by End Use: Diagnostic Laboratories, Hospitals, and Others
  • 4.4: APAC HIV Diagnostic Market
    • 4.4.1: APAC HIV Diagnostics Market by Test Type: Antibody Tests, Viral Load Tests, CD4 Tests, and Others
    • 4.4.2: APAC HIV Diagnostics Market by End Use: Diagnostic Laboratories, Hospitals, and Others
  • 4.5: ROW HIV Diagnostic Market
    • 4.5.1: ROW HIV Diagnostics Market by Test Type: Antibody Tests, Viral Load Tests, CD4 Tests, and Others
    • 4.5.2: ROW HIV Diagnostics Market by End Use: Diagnostic Laboratories, Hospitals, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global HIV Diagnostic Market by Product
    • 6.1.2: Growth Opportunities for the Global HIV Diagnostic Market by Test Type
    • 6.1.3: Growth Opportunities for the Global HIV Diagnostic Market by End Use
    • 6.1.4: Growth Opportunities for the Global HIV Diagnostics Market by Region
  • 6.2: Emerging Trends in the Global HIV Diagnostic Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global HIV Diagnostic Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global HIV Diagnostic Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Siemens Healthineers
  • 7.2: F. Hoffmann-La Roche
  • 7.3: Abbott Laboratories
  • 7.4: Danaher
  • 7.5: Thermo-Fisher Scientific